Noven Pharmaceuticals
Focus: Noven Pharmaceuticals is a specialty pharmaceutical company founded in 1999, headquartered in Miami, focused on small-molecule therapies delivered via transdermal systems. The company derives 71% of revenue from a single product, COMBIPATCH, positioning it as a niche player in women's health and CNS stimulant markets.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Open Jobs
7+153 this month
Hot — 180 jobs added in 30d
Net +153 (180 new, 27 removed). Aggressive expansion phase.
Should You Work at Noven Pharmaceuticals?
AI assessmentNoven represents a higher-risk specialty play suitable for professionals seeking transdermal/CNS expertise and pipeline optionality, but with material re-risk if Phase 3 programs fail or COMBIPATCH loses exclusivity faster than anticipated.
Why Work Here
- Established transdermal delivery expertise with multiple Phase 3 programs advancing in CNS and pain management—DAYTRANA (methylphenidate patch) and d-amphetamine patch represent platform innovation leverage.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
9 Phase 3+
LOE Risk
1 in 5yr
MINIVELLE
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$5M Part DDeclining
LOE Approaching
Noven's revenue anchor (71% of total), but approaching loss of exclusivity with no disclosed LOE date—represents primary near-term restructuring risk.
Help build intelligence for Noven Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.